Immunologic effects of rituximab on the human spleen in immune thrombocytopenia

Factors implicated in the generation and persistence of long-lived plasma cell-mediated autoimmunity

(2011) Marisa Neves et al.   AUTOIMMUNITY REVIEWS

Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents

(2010) W. Bao et al.   BLOOD

Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura

(2010) T. Tsubakio et al.   BRITISH JOURNAL OF HAEMATOLOGY

CD20-depleting therapy in autoimmune diseases: from basic research to the clinic

(2009) F. Perosa et al.   JOURNAL OF INTERNAL MEDICINE

Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs

(2009) K. Bocian et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Differential Responses of Human Regulatory T Cells (Treg) and Effector T Cells to Rapamycin

(2009) Laura Strauss et al.   PLoS One

Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab

(2008) R. Stasi et al.   BLOOD

Recruitment of T cells into bone marrow of ITP patients possibly due to elevated expression of VLA-4 and CX3CR1

(2008) B. Olsson et al.   BLOOD

Defective circulating CD25 regulatory T cells in patients with chronic immune thrombocytopenic purpura

(2008) J. Yu et al.   BLOOD

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study

(2008) B. Godeau et al.   BLOOD

Role of the spleen in peripheral memory B-cell homeostasis in patients with autoimmune thrombocytopenia purpura

(2008) Lorena Martinez-Gamboa et al.   CLINICAL IMMUNOLOGY

Splenic macrophages maintain the anti-platelet autoimmune response via uptake of opsonized platelets in patients with immune thrombocytopenic purpura

(2008) M. KUWANA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS